Back to discover
Disease
Gastritis
Late-stage therapeutic developmentEmerging research
2
Publications
18
Clinical trials
2
Related conditions
2024
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates.
Research2024-02-23Gut
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial expected to report results, the earliest in Q3 2026.
Major developments
Major trial resultsHigh impact
Results posted2026-04-21
Upcoming trial readoutImportant
Results expected Q3 20262025-12-02
Clinical MilestonesViewHide
Results posted
Results expected
Recently completed
- 2026-02-23A Phase 2, 2-Part, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Gastritis With or Without Eosinophilic DuodenitisPrimary completion
- 2026-02-17Vedolizumab for the Treatment of Collagenous GastritisPrimary completion
- 2025-12-30To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology (CGDP) in Schoolchildren in the Primary Health Care System.Primary completion
- 2025-10-01Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical TrialPrimary completion
Activity timeline6
- 2026-04-21ClinicalRandomized, Double-Blind, Placebo-Controlled Trial of Meriva® (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric CarcinogenesisResults posted
- 2026-02-23ClinicalA Phase 2, 2-Part, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Gastritis With or Without Eosinophilic DuodenitisPrimary completion
- 2026-02-17ClinicalVedolizumab for the Treatment of Collagenous GastritisPrimary completion
- 2025-12-30ClinicalTo Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology (CGDP) in Schoolchildren in the Primary Health Care System.Primary completion
- 2025-12-02ClinicalEfficacy and Safety of Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment: A Prospective, Multicenter, Randomized Controlled TrialResults expected Q3 2026
- 2025-10-01ClinicalEfficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical TrialPrimary completion
Clinical trials
The current development programme across all trial phases.
Clinical programme
18
6
11
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20172024
Most influential
Major themes4
- Helicobacter pylori2
- Gastritis1
- Helicobacter Infections1
- Stomach Neoplasms1
Leading journals1
- Gut2
Leading researchers8
- El-Omar EM2
- Graham DY2
- Kuipers EJ2
- Malfertheiner P2
- Rokkas T2
- Rugge M2
- Atherton J1
- Axon AT1
Affiliations (unnormalised)6
- Erasmus University Medical Center2
- University of Padova2
- Baylor College of Medicine1
- General Infirmary Leeds1
- Henry Dunant Hospital1
- Henry Dunant Hospital Center1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.